544 related articles for article (PubMed ID: 23919640)
1. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
Sawada N; Liao JK
Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
[TBL] [Abstract][Full Text] [Related]
2. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
Zhou Q; Liao JK
Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
[TBL] [Abstract][Full Text] [Related]
3. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.
Zhou Q; Gensch C; Liao JK
Trends Pharmacol Sci; 2011 Mar; 32(3):167-73. PubMed ID: 21242007
[TBL] [Abstract][Full Text] [Related]
4. Rho kinase: an important mediator of atherosclerosis and vascular disease.
Zhou Q; Liao JK
Curr Pharm Des; 2009; 15(27):3108-15. PubMed ID: 19754385
[TBL] [Abstract][Full Text] [Related]
5. Statins inhibit Rho kinase activity in patients with atherosclerosis.
Nohria A; Prsic A; Liu PY; Okamoto R; Creager MA; Selwyn A; Liao JK; Ganz P
Atherosclerosis; 2009 Aug; 205(2):517-21. PubMed ID: 19167712
[TBL] [Abstract][Full Text] [Related]
6. Rho GTPases, statins, and nitric oxide.
Rikitake Y; Liao JK
Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
[TBL] [Abstract][Full Text] [Related]
7. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.
Liu PY; Liu YW; Lin LJ; Chen JH; Liao JK
Circulation; 2009 Jan; 119(1):131-8. PubMed ID: 19075102
[TBL] [Abstract][Full Text] [Related]
8. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
Liao JK
Curr Atheroscler Rep; 2007 Nov; 9(5):384-8. PubMed ID: 18001621
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic Benefits of Statins in Cardiovascular Diseases.
Wasim R; Ansari TM; Ahsan F; Siddiqui MH; Singh A; Shariq M; Parveen S
Drug Res (Stuttg); 2022 Nov; 72(9):477-486. PubMed ID: 35868336
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
11. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
[TBL] [Abstract][Full Text] [Related]
12. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway.
Kidera Y; Tsubaki M; Yamazoe Y; Shoji K; Nakamura H; Ogaki M; Satou T; Itoh T; Isozaki M; Kaneko J; Tanimori Y; Yanae M; Nishida S
J Exp Clin Cancer Res; 2010 Sep; 29(1):127. PubMed ID: 20843370
[TBL] [Abstract][Full Text] [Related]
13. Physiological role of ROCKs in the cardiovascular system.
Noma K; Oyama N; Liao JK
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C661-8. PubMed ID: 16469861
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statins: new therapeutic targets in drug design.
Bedi O; Dhawan V; Sharma PL; Kumar P
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):695-712. PubMed ID: 27146293
[TBL] [Abstract][Full Text] [Related]
15. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase (ROCK) inhibitors.
Liao JK; Seto M; Noma K
J Cardiovasc Pharmacol; 2007 Jul; 50(1):17-24. PubMed ID: 17666911
[TBL] [Abstract][Full Text] [Related]
17. Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins.
Cai A; Zhou Y; Li L
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124206
[No Abstract] [Full Text] [Related]
18. 3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA/ROCK pathway regulated by RhoA prenylation.
Rattan S
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G962-9. PubMed ID: 20378830
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Effects of Statins on the Cardiovascular System.
Oesterle A; Laufs U; Liao JK
Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
